Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Translation, Cross-Cultural Adaptation and Validation of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) for Italian-speaking Cancer Patients

NCT02381054 is registered in ClinicalTrials.gov with Italian PRO-CTCAE Study Group as lead sponsor.

NCT NCT02381054
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02381054 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Translation, Cross-Cultural Adaptation and Validation of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) for Italian-speaking Cancer Patients
Lead sponsor
Italian PRO-CTCAE Study Group
Phase
Observational
Overall status
Completed
Start date
May 31, 2015
Completion date
June 22, 2017
Enrollment
233 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

cancer